Home / Intelligence / White Papers / How Five Oncology Treatment Paradigms Determine Strategic Choices for Commercial Success
New targeted oncology treatment regimens have changed cancer treatment. This white paper charts that development and analyzes five different approaches, providing an overview of how these paradigms determine strategic choices for commercial success. We observe that:
- The oncology treatment landscape has five distinct treatment paradigms.
- Competition, routes of administration, and market dynamics differ dramatically for each paradigm.
- The approach to commercialization needs to differ for each paradigm to increase uptake and ensure successful market penetration.
Related Intelligence
Blog
2025 Oncology Mid-Year Check-in: Reflections & Expectations
Reflecting on the first half of 2025 including data from AACR, ASCO and EHA, we see several notable trends continuing to shape the oncology landscape. While development follows momentum observed the last few years, these learnings provide a clearer understanding into the next wave of innovation. Immunotherapy Moves Earlier in the Journey One of the […]
Read More
Blog
Joint Clinical Assessment in the EU: What Life Sciences Companies Need to Know
March 2025 marked a pivotal moment for pharmaceutical and biotech companies operating in the European Union (EU) as the first two molecules began to proceed through the Joint Clinical Assessment (JCA) process. At a recent seminar hosted by Trinity Life Sciences, stakeholders gathered to explore the implications of this new regulatory framework and how to […]
Read More
Webinars
Trinity Annual Drug Index
Available On Demand
White Paper & On-demand Webinar: This report, the seventh in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the performance of novel drugs approved by the FDA in 2021, scoring each […]
Watch Now